SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-099411
Filing Date
2019-04-05
Accepted
2019-04-05 17:17:03
Documents
166
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d691824d20f.htm 20-F 2578434
2 EX-1.1 d691824dex11.htm EX-1.1 83313
3 EX-4.23 d691824dex423.htm EX-4.23 45597
4 EX-4.24 d691824dex424.htm EX-4.24 86790
5 EX-8.1 d691824dex81.htm EX-8.1 2438
6 EX-12.1 d691824dex121.htm EX-12.1 9820
7 EX-13.1 d691824dex131.htm EX-13.1 3101
8 EX-15.1 d691824dex151.htm EX-15.1 4893
9 EX-15.2 d691824dex152.htm EX-15.2 2032
16 GRAPHIC g691824g05n06.jpg GRAPHIC 94404
17 GRAPHIC g691824g08a58.jpg GRAPHIC 91502
18 GRAPHIC g691824g13q62.jpg GRAPHIC 66140
19 GRAPHIC g691824g17l32.jpg GRAPHIC 51082
20 GRAPHIC g691824g18n43.jpg GRAPHIC 15028
21 GRAPHIC g691824g28h46.jpg GRAPHIC 39809
22 GRAPHIC g691824g35p02.jpg GRAPHIC 38951
23 GRAPHIC g691824g86l97.jpg GRAPHIC 66871
24 GRAPHIC g691824img1.jpg GRAPHIC 6588
  Complete submission text file 0001193125-19-099411.txt   15493192

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT cyad-20181231.xml EX-101.INS 3655214
11 XBRL TAXONOMY EXTENSION SCHEMA cyad-20181231.xsd EX-101.SCH 185832
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cyad-20181231_cal.xml EX-101.CAL 156131
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cyad-20181231_def.xml EX-101.DEF 449914
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyad-20181231_lab.xml EX-101.LAB 1000296
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyad-20181231_pre.xml EX-101.PRE 716524
Mailing Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435
Business Address RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 32 10 394 100
CELYAD S.A. (Filer) CIK: 0001637890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37452 | Film No.: 19735903
SIC: 2834 Pharmaceutical Preparations